Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases

This publication has 45 references indexed in Scilit:

• In Vivo Inhibition of Osteoblastic Metalloproteinases Leads to Increased Trabecular Bone Mass
  Journal of Bone and Mineral Research, 2004
• Matrix Metalloproteinases (MMPs) Safeguard Osteoblasts from Apoptosis during Transdifferentiation into Osteocytes: MT1-MMP Maintains Osteocyte Viability
  DNA and Cell Biology, 2004
• Sex Steroids and Bone
  Recent Progress in Hormone Research, 2002
• Estrogen modulates estrogen receptor ? and ? expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice
  Journal of Cellular Biochemistry, 2001
• Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells
  Journal of Cellular Physiology, 2000
• The Expression of Metalloproteinase-2, −9, and −14 and of Tissue Inhibitors-1 and −2 Is Developmentally Modulated During Osteogenesis In Vitro, the Mature Osteoblastic Phenotype Expressing Metalloproteinase-14
  Journal of Bone and Mineral Research, 2000
• Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone
  Cell and tissue research, 2000
• Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system
  Biochemical Journal, 2000
• Quantitative Polymerase Chain Reaction of Lysyl Oxidase mRNA in Malignantly Transformed Human Cell Lines Demonstrates That Their Low Lysyl Oxidase Activity Is Due to Low Quantities of Its mRNA and Low Levels of Transcription of the Respective Gene
  Journal of Biological Chemistry, 1995
• Direct resorption of bone by human breast cancer cells in vitro
  Nature, 1978